Powerpack

Unlock full stockrow access for only $9.90/month and boost yourself as an investor.

  • Full quarterly history

    Every quarter and TTM period we hold, not just the last 12.

  • Analyst estimates

    Three years of forward estimates and dividend forecasts.

  • Unlimited screener

    All results, unlimited saved screens, email when a screen changes.

  • Unlimited Excel

    Full workbooks and screener exports.

  • Unlimited follows

See Powerpack
Screener Weekly Summary Pricing

iRadimed Corporation IRMD

Healthcare  —  Medical Devices
85.76 0.56 0.66% as of 25 Sep
Market cap
$1.1B
P/E
47.1×
Revenue Champion (5y)
Growth Flags show if company had growth for consecutive years
Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

iRadimed Corporation (IRMD) Business Profile

Updated before January 2025

Company Overview

iRadimed Corporation (NASDAQ: IRMD) is a leading provider of innovative medical devices specializing in non-magnetic MRI-compatible patient care products. Founded in 1992 by Roger Susi, a pioneer in the field of MRI-compatible medical equipment, the company is headquartered in Winter Springs, Florida, USA. iRadimed has established itself as a key player in the healthcare industry by focusing on the development and commercialization of advanced medical technologies that enhance patient safety and improve clinical workflows. The company is led by a team of experienced executives, including Roger Susi, who serves as Chairman and Chief Technology Officer, and Michael Morabito, the current President and Chief Executive Officer.

Core Business Segments

MRI-Compatible Infusion Systems

One of iRadimed’s flagship product lines is its MRI-compatible infusion systems. These systems are designed to safely deliver medications and fluids to patients undergoing MRI procedures. The MRidium® 3860+ MRI Infusion System is a standout product in this category, offering unparalleled safety and performance. It features non-magnetic components, advanced dose calculation software, and wireless remote control capabilities, making it a preferred choice for hospitals and imaging centers worldwide.

MRI-Compatible Patient Monitors

Another core segment of iRadimed’s business is its MRI-compatible patient monitoring systems. The iMagox® 2460 MRI-compatible patient monitor is a state-of-the-art device that provides continuous monitoring of vital signs, such as heart rate, oxygen saturation, and blood pressure, during MRI scans. This product ensures patient safety and comfort while maintaining the integrity of the MRI environment.

Accessories and Consumables

In addition to its primary product lines, iRadimed offers a range of accessories and consumables that complement its MRI-compatible devices. These include non-magnetic IV tubing, infusion sets, and other disposable items designed to work seamlessly with the company’s core products.

Business Model

iRadimed operates on a business model that integrates product innovation, customer support, and recurring revenue streams. The company generates revenue through the sale of its MRI-compatible devices, as well as through the ongoing sale of consumables and accessories. iRadimed also provides training and technical support to its customers, ensuring optimal product performance and customer satisfaction. By focusing on niche markets with high barriers to entry, iRadimed has established a strong competitive position and a loyal customer base.

Strategic Direction

iRadimed is committed to driving growth through innovation and market expansion. The company is actively investing in research and development to introduce new products and enhance existing ones. Sustainability is also a key focus, with efforts to minimize the environmental impact of its operations and products. In terms of market expansion, iRadimed is exploring opportunities in emerging markets and expanding its global distribution network. The company is also evaluating potential new product categories, such as MRI-compatible ventilators and anesthesia machines, to further diversify its portfolio.

Competitive Landscape

iRadimed operates in a highly specialized market with limited direct competition. However, it faces competition from companies that offer alternative solutions for patient care during MRI procedures. Key competitors include Philips Healthcare, GE Healthcare, and Siemens Healthineers, which provide MRI-compatible monitoring and infusion systems. Despite this competition, iRadimed’s focus on innovation, quality, and customer service has allowed it to maintain a leadership position in its niche market.

Risk Factors

Like any business, iRadimed faces several risks that could impact its performance. These include:

  • Market Dependence: A significant portion of iRadimed’s revenue comes from its MRI-compatible devices. Any decline in demand for these products could adversely affect the company’s financial performance.
  • Regulatory Challenges: As a medical device manufacturer, iRadimed must comply with stringent regulatory requirements. Delays or failures in obtaining regulatory approvals could hinder product launches and market expansion.
  • Supply Chain Disruptions: The company relies on a global supply chain for the production of its devices. Disruptions in the supply chain, such as shortages of critical components, could impact production and delivery timelines.
  • Technological Obsolescence: Rapid advancements in medical technology could render iRadimed’s products obsolete if the company fails to innovate and adapt.

Recent Developments

iRadimed has recently introduced several new products and initiatives to strengthen its market position. In 2023, the company launched an upgraded version of its MRidium® 3860+ MRI Infusion System, featuring enhanced software capabilities and improved user interface. Additionally, iRadimed has expanded its global footprint by entering new markets in Asia and South America. The company has also implemented a sustainability program aimed at reducing waste and energy consumption across its operations.

Investment Considerations

Strengths

  • Market Leadership: iRadimed is a leader in the niche market of MRI-compatible medical devices, with a strong brand reputation and loyal customer base.
  • Innovative Products: The company’s focus on innovation has resulted in a portfolio of high-quality, reliable products that meet the needs of healthcare providers.
  • Recurring Revenue: The sale of consumables and accessories provides a steady stream of recurring revenue, enhancing financial stability.
  • Growth Potential: iRadimed’s expansion into emerging markets and new product categories offers significant growth opportunities.

Risks

  • Market Concentration: Dependence on a limited number of products and markets could pose risks if demand declines.
  • Regulatory Hurdles: Compliance with complex regulatory requirements could delay product launches and increase costs.
  • Competitive Pressure: While iRadimed operates in a niche market, competition from larger, well-established companies could impact market share.

Conclusion

iRadimed Corporation is a market leader in MRI-compatible medical devices, with a strong focus on innovation, quality, and customer satisfaction. The company’s commitment to research and development, coupled with its strategic expansion efforts, positions it well for future growth. While there are risks associated with market concentration and regulatory challenges, iRadimed’s strengths in product innovation and recurring revenue generation make it an attractive investment opportunity. As the demand for MRI-compatible medical devices continues to grow, iRadimed is well-positioned to capitalize on this trend and maintain its leadership in the industry.